Abstract: CD Genomics' cancer panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple cancer diseases. CD Genomics utilizes targeted NGS sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, and even to detect low-frequency variations in cancer-associated genes. Targeted NGS sequencing facilitates the sequencing of a large number of genes and samples in a single and cost-effective assay. CD Genomics provides a variety of cancer panels for your cancer-related research. Summary: CD Genomics' cancer panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple cancer diseases. References: https://www.cd-genomics.com/diseasepanel/
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Improving the Chemical Synthesis and Performance of Extended-Length Guide RNAs for Genome Editing and Control of Gene Expression
Laurakay Bruhn, Bo Curry, Rob Kaiser, Ben Lunstad, Ryan McCaffrey, Joel Myerson, Subhadeep Roy, Daniel Ryan, Israel Steinfeld, David Taussig, Justin Townsend, Suhani Thakker, Doug Dellinger
Modulating the Activity of CRISPR-Cas with Chemical Modifications in Single-Guide RNAs
Daniel Ryan, David Taussig, Suhani Thakker, Israel Steinfeld, Ben Lunstad, Rob Kaiser, Ryan McCaffrey, Justin Townsend, Patrick Chaffey, Bo Curry, Doug Dellinger, Laurakay Bruhn
Build A Gene Mutation Panel with Non-NGS Technologies - CD Genomics
Why Cancer Panels Stand Out for Cancer Research
Efficient Genotyping and Powerful Data Analysis with the Agilent ZAG DNA Analyzer System
Whitney Pike, Solange Borg, Chava Pocernich, and Kyle Luttgeharm